These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17035711)

  • 21. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.
    Ceriello A; De Cosmo S; Rossi MC; Lucisano G; Genovese S; Pontremoli R; Fioretto P; Giorda C; Pacilli A; Viazzi F; Russo G; Nicolucci A;
    Diabetes Obes Metab; 2017 Nov; 19(11):1570-1578. PubMed ID: 28432733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated baseline glomerular filtration rate (GFR) is independently associated with a more rapid decline in renal function of patients with type 1 diabetes.
    Thomson HJ; Ekinci EI; Radcliffe NJ; Seah JM; MacIsaac RJ; Jerums G; Premaratne E
    J Diabetes Complications; 2016 Mar; 30(2):256-61. PubMed ID: 26794645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular hyperfiltration and increased glomerular filtration surface are associated with renal function decline in normo- and microalbuminuric type 2 diabetes.
    Moriya T; Tsuchiya A; Okizaki S; Hayashi A; Tanaka K; Shichiri M
    Kidney Int; 2012 Mar; 81(5):486-93. PubMed ID: 22157655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nephrotic range proteinuria as a strong risk factor for rapid renal function decline during pre-dialysis phase in type 2 diabetic patients with severely impaired renal function.
    Kitai Y; Doi Y; Osaki K; Sugioka S; Koshikawa M; Sugawara A
    Clin Exp Nephrol; 2015 Dec; 19(6):1037-43. PubMed ID: 25680889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus.
    Bruce R; Williams L; Cundy T
    Aust N Z J Med; 1994 Aug; 24(4):390-5. PubMed ID: 7980236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annual deterioration of renal function in hypertensive patients with and without diabetes.
    Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
    Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.
    Gall MA; Nielsen FS; Smidt UM; Parving HH
    Diabetologia; 1993 Oct; 36(10):1071-8. PubMed ID: 8243857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for progression of renal disease in patient with diabetic nephropathy.
    Unsal A; Koc Y; Basturk T; Akgun AO; Sakaci T; Ahbap E
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of clinical arterial pressure, home-arterial pressure measurement, and ambulatory arterial pressure monitoring in patients with type II diabetes mellitus and diabetic nephropathy].
    Lou LM; Gimeno JA; Gómez Sánchez R; Labrador T; Beguer P; Lou MT; Boned B; Aguilar E
    Nefrologia; 2002; 22(2):179-89. PubMed ID: 12085419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of progression of diabetic nephropathy: implication for timing of kidney transplantation.
    Cheng SS; Wilson DM; Munn SR
    Clin Transplant; 1997 Aug; 11(4):334-6. PubMed ID: 9267725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
    Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
    Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking and progression of diabetic nephropathy in type 1 diabetes.
    Hovind P; Rossing P; Tarnow L; Parving HH
    Diabetes Care; 2003 Mar; 26(3):911-6. PubMed ID: 12610058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of residual renal function was not associated with glycemic control in patients on peritoneal dialysis.
    Sung SA; Hwang YH; Kim S; Kim SG; Oh J; Chung W; Lee SY; Ahn C; Oh KH
    Perit Dial Int; 2011; 31(2):154-9. PubMed ID: 21282376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study.
    Gómez-Marcos MÁ; Recio-Rodríguez JI; Gómez-Sánchez L; Agudo-Conde C; Rodríguez-Sanchez E; Maderuelo-Fernandez J; Gomez-Sanchez M; García-Ortiz L;
    Cardiovasc Diabetol; 2015 Oct; 14():132. PubMed ID: 26427534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.
    Torffvit O; Agardh CD
    J Diabetes Complications; 2001; 15(6):307-13. PubMed ID: 11711324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
    Kanaoka T; Tamura K; Moriya T; Tanaka K; Konno Y; Kondoh S; Toyoda M; Umezono T; Fujikawa T; Ohsawa M; Dejima T; Maeda A; Wakui H; Haku S; Yanagi M; Mitsuhashi H; Ozawa M; Okano Y; Ogawa N; Yamakawa T; Mizushima S; Suzuki D; Umemura S
    Clin Exp Hypertens; 2011; 33(4):255-63. PubMed ID: 21699452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.